advertising
-
1
Meberg R, Kenyon E, Bierman R, et al: Characterization of plantar verrucae among individuals with human immunodeficiency virus. .JAPMA 88::442. ,1998. .
-
2
Kirby EJ, Shereff MJ, Lewis MM: Soft-tissue tumors and tumor-like lesions of the foot: an analysis of eighty-three cases. .J Bone Joint Surg Am 71::621. ,1989. .
-
4
Brooks G, Butel J, Ornston L: Jawetz, Melnick, and Adelberg’s Medical Microbiology, 19th Ed, Appleton & Lange, Norfolk, CT, 1991..
-
5
Bunney M, Benton C, Cubie H: Viral Warts: Biology and Treatment, 2nd Ed, Oxford Medical Publications, Oxford, 1992..
-
6
Viac J, Chomel J, Chardonnet Y, et al: Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas. .J Med Virol 32::18. ,1990. .
-
7
Jenkin W: “Management of Viral Infections of the Skin and Nail,” in Surgery Lecture Manual, p 14, California College of Podiatric Medicine, San Francisco, 1994..
-
8
Memar O, Cirelli R, Lee P, et al: Cutaneous manifestations of HIV-1 infection. .JAPMA 85::362. ,1995. .
-
9
Barbosa P: Plantar verrucae and HIV infection. .Clin Podiatr Med Surg 15::317. ,1998. .
-
10
Kang S, Fitzpatrick T: Debilitating verruca vulgaris in a patient infected with the human immunodeficiency virus. .Arch Dermatol 130::294. ,1994. .
-
11
Burns S: Podiatric manifestations of AIDS. .JAPMA 80::15. ,1990. .
-
12
Adler J: Pedal infectious disease associated with acquired immunodeficiency syndrome. .Clin Podiatr Med Surg 9::837. ,1992. .
-
13
Dover J, Johnson R: Cutaneous manifestations of human immunodeficiency virus infection. .Arch Dermatol 27::1383. ,1991. .
-
14
Soltani SK, Kenyon E, Barbosa P: Chronic and aggressive plantar verrucae in a patient with HIV. .JAPMA 86::555. ,1996. .
-
15
Kenyon E, Loveland L, Kilpatrick R, et al: Epidemiology of plantar verrucae in HIV-infected individuals. .J Acquir Immune Defic Syndr Hum Retrovirol 17::94. ,1998. .
Plantar Verrucae in Patients with Human Immunodeficiency Virus
Clinical Presentation and Treatment Response
Search for other papers by Jeffrey M. Whitaker in
Current site
Google Scholar
PubMed
Search for other papers by Geoffrey L. Gaggero in
Current site
Google Scholar
PubMed
Search for other papers by Lacey Loveland in
Current site
Google Scholar
PubMed
Search for other papers by Lolita Segura in
Current site
Google Scholar
PubMed
Search for other papers by Peter Barbosa in
Current site
Google Scholar
PubMed
Several previous studies have yielded data showing that plantar and other cutaneous verrucae follow a more aggressive course in patients infected with human immunodeficiency virus (HIV) than in uninfected individuals. A pilot study was undertaken to identify trends in a sample population that would support this characterization of plantar verrucae in HIV+ patients and to determine whether there are differences in treatment response between HIV+ and HIV− patients. The results show that the HIV+ patients in the study presented with a significantly greater number and total area of lesions than did the HIV− patients. Furthermore, the HIV+ patients experienced a greater frequency of recurrence of their lesions following treatment with surgical curettage. These findings should provide the foundation for other extensive, multicenter studies to further characterize the treatment response of these lesions in HIV+ patients and to develop effective guidelines for their management. (J Am Podiatr Med Assoc 91(2): 79-84, 2001)
advertising
